A Simplified Regimen to Prevent Nausea and Vomiting Using Netupitant/Palonosetron in Germ Cell Cancer Patients Receiving Chemotherapy
Clinical trial NCT07662200 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07662200
- Sponsor
- Ottawa Hospital Research Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2027-08-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.